DEA Bans Mind-Bending 3-MeO-PCP in Schedule I Crackdown
Published Date: 3/23/2026
Rule
Summary
Starting April 22, 2026, the DEA is putting 3-methoxyphencyclidine (3-MeO-PCP) into Schedule I, meaning it’s now officially a highly controlled substance with strict rules. This affects anyone who makes, sells, studies, or even possesses 3-MeO-PCP, who will face serious legal consequences. This move helps the U.S. follow international drug laws and keeps communities safer.
Analyzed Economic Effects
5 provisions identified: 1 benefits, 4 costs, 0 mixed.
3‑MeO‑PCP Placed Into Schedule I
Starting April 22, 2026, the Drug Enforcement Administration places 3-methoxyphencyclidine (3-MeO-PCP) in Schedule I of the Controlled Substances Act. That means possession, manufacture, distribution, importation, exportation, or other handling of 3-MeO-PCP is subject to the strict criminal, civil, and administrative penalties that apply to Schedule I substances.
DEA Registration Required to Handle 3‑MeO‑PCP
If you handle 3-MeO-PCP (manufacture, distribute, research with, import, export, or possess), you must register with DEA under 21 U.S.C. 822, 823, 957, and 958 and follow 21 CFR parts 1301 and 1312. Any person who currently handles 3-MeO-PCP and is not registered must submit an application and may not continue to handle it unless DEA approves the registration before the effective date.
Strict Compliance Rules for Registrants
DEA registrants handling 3-MeO-PCP must follow Schedule I controls including security requirements, labeling and packaging rules, quotas for manufacture, and recordkeeping and reporting. Registrants must take an initial inventory on the date they first handle controlled substances and thereafter inventory all controlled substances (including 3-MeO-PCP) every two years, and must comply with disposal rules and order form, import/export, and quota requirements.
Research Allowed but Requires Schedule I Registration
The final rule states that placing 3-MeO-PCP in Schedule I does not preclude research, but researchers must comply with DEA's Schedule I registration processes and requirements to conduct research legally. Those who wish to study 3-MeO-PCP must follow the DEA registration process for Schedule I substances before engaging in research.
DEA Says Limited Small‑Entity Economic Impact
DEA certifies under the Regulatory Flexibility Act that this final rule will not have a significant economic impact on a substantial number of small entities. The agency notes there appear to be no legitimate marketed sources for 3-MeO-PCP in the U.S., though legitimate suppliers sell it for scientific research, and there is no evidence of significant diversion from legitimate suppliers.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-10090 — Exempt Chemical Preparations Under the Controlled Substances Act
The Drug Enforcement Administration (DEA) reviewed and decided on applications for special chemical mixtures that don’t fall under strict drug rules, covering requests from July 2025 to March 2026. Some mixtures got approved, others denied, and a few listings were fixed from earlier notices. If you’re involved with these chemicals, you’ve got until July 20, 2026, to share your thoughts—no fees or big costs involved, just your voice!
2026-09566 — Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I
Starting May 13, 2026, the DEA officially puts CUMYL-PEGACLONE—a chemical that can be risky—into Schedule I, the strictest drug category. This means anyone making, selling, or using it now faces tough rules and penalties. This move helps the U.S. follow international drug laws and keeps communities safer without any new fees or costs.
2026-08595 — Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance
The DEA is giving hexahydrocannabinol (HHC) its own official spot on the list of Schedule I drugs, making it clear that HHC is controlled separately from other similar substances. This change starts May 4, 2026, and affects anyone making, selling, or using HHC, which stays illegal under federal law. No new fees or costs are introduced, but the update helps law enforcement and businesses know exactly where HHC stands.
2026-08588 — Bulk Manufacturer of Controlled Substances Application: Patheon API Inc.
Patheon API Inc. wants to make large amounts of special research drugs like dimethyltryptamine and psilocybin. This affects researchers and companies involved in clinical trials, with a chance to comment or ask for a hearing by July 6, 2026. No money changes are mentioned, but this move could speed up important medical studies.
2026-08587 — Importer of Controlled Substances Application: ANI Pharmaceuticals Inc.
ANI Pharmaceuticals wants to import certain controlled drugs like Levorphanol and Tapentadol. People who make or use these drugs can share their thoughts or ask for a hearing by June 3, 2026. This move could affect drug availability and regulation, so keep an eye on the deadline to have your say!
Previous / Next Documents
Previous: 2026-05607 — Air Plan Approval; Texas; Reasonably Available Control Technology in the Dallas-Fort Worth Ozone Nonattainment Area
The EPA is giving a thumbs-up to Texas’ updated air pollution rules for big factories in the Dallas-Fort Worth area to help cut smog-causing chemicals. These changes kick in on April 22, 2026, and aim to make the air cleaner without breaking the bank. If you’re a business owner or live in DFW, expect better air and smarter pollution controls soon!
Next: 2026-05634 — Minor Child Definition for Form LM-30 Labor Organization Officer and Employee Report
The Department of Labor is changing the definition of a “minor child” on the Form LM-30 from under 21 years old to under 18 years old. This update affects labor union officers and employees who file these reports, making it easier to comply without losing important financial disclosure info. The new rule kicks in April 22, 2026, for reports covering fiscal years starting July 1, 2026, with no extra costs involved.